GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (FRA:OC9) » Definitions » Institutional Ownership

Omnicell (FRA:OC9) Institutional Ownership : 71.84% (As of Jun. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Omnicell Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Omnicell's institutional ownership is 71.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Omnicell's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Omnicell's Float Percentage Of Total Shares Outstanding is 69.12%.


Omnicell Institutional Ownership Historical Data

The historical data trend for Omnicell's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Institutional Ownership Chart

Omnicell Historical Data

The historical data trend for Omnicell can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 83.12 84.83 80.68 79.84 77.56 76.48 74.27 72.63 72.01 71.84

Omnicell Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Omnicell (FRA:OC9) Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Omnicell (FRA:OC9) Headlines

No Headlines